NO803910L - Fremgangsmaate for immunologisk paavisning av kreft i vev hos mennesker. - Google Patents

Fremgangsmaate for immunologisk paavisning av kreft i vev hos mennesker.

Info

Publication number
NO803910L
NO803910L NO803910A NO803910A NO803910L NO 803910 L NO803910 L NO 803910L NO 803910 A NO803910 A NO 803910A NO 803910 A NO803910 A NO 803910A NO 803910 L NO803910 L NO 803910L
Authority
NO
Norway
Prior art keywords
antibodies
cells
nucleoli
human
antigens
Prior art date
Application number
NO803910A
Other languages
English (en)
Norwegian (no)
Inventor
Harris Busch
Rose K Busch
Ferenc Gyorkey
Phyllis Gyorkey
Frances M Davis
Karel Smetana
Original Assignee
Baylor College Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Medicine filed Critical Baylor College Medicine
Publication of NO803910L publication Critical patent/NO803910L/no
Priority to NO864091A priority Critical patent/NO864091D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • G01N33/57595—

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO803910A 1980-01-04 1980-12-22 Fremgangsmaate for immunologisk paavisning av kreft i vev hos mennesker. NO803910L (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO864091A NO864091D0 (no) 1980-01-04 1986-10-14 Antigener fra isolerte nukleoli og nukleaere ekstrakter samt diagnostisk utstyr for bruk ved immunologisk paavisning av krefter.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA000343088A CA1157373A (en) 1980-01-04 1980-01-04 Detection of human cancer cells with antibodies to human cancer nucleolar antigen(s)

Publications (1)

Publication Number Publication Date
NO803910L true NO803910L (no) 1981-07-06

Family

ID=4115973

Family Applications (2)

Application Number Title Priority Date Filing Date
NO803910A NO803910L (no) 1980-01-04 1980-12-22 Fremgangsmaate for immunologisk paavisning av kreft i vev hos mennesker.
NO850005A NO850005L (no) 1980-01-04 1985-01-02 Nukleaert preparat, fremgangsmaate for rensing av nukleolaere antigener samt fremgangsmaate for rensing av antistoffer

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO850005A NO850005L (no) 1980-01-04 1985-01-02 Nukleaert preparat, fremgangsmaate for rensing av nukleolaere antigener samt fremgangsmaate for rensing av antistoffer

Country Status (27)

Country Link
JP (1) JPS56101553A (oth)
KR (1) KR850001770B1 (oth)
AR (1) AR232046A1 (oth)
AT (1) AT373397B (oth)
AU (1) AU535024B2 (oth)
BE (1) BE886935A (oth)
CA (1) CA1157373A (oth)
CH (1) CH659328A5 (oth)
DE (1) DE3047654A1 (oth)
DK (1) DK554980A (oth)
ES (2) ES8206855A1 (oth)
FI (1) FI810007L (oth)
FR (1) FR2484650B1 (oth)
GB (1) GB2067286B (oth)
GR (1) GR72850B (oth)
IE (1) IE50760B1 (oth)
IL (1) IL61641A (oth)
IT (1) IT1172216B (oth)
LU (1) LU83015A1 (oth)
NL (1) NL8007128A (oth)
NO (2) NO803910L (oth)
NZ (1) NZ195756A (oth)
OA (1) OA06713A (oth)
PH (5) PH18765A (oth)
PT (1) PT72301B (oth)
SE (1) SE450665B (oth)
ZA (1) ZA807754B (oth)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487830A (en) * 1982-05-14 1984-12-11 American Hoechst Corporation Enzyme/immunofluorescent assay for autoantibodies
JPS5990052A (ja) * 1982-11-16 1984-05-24 Katsu Taniguchi モノクロ−ナル特異抗体を用いたメラノ−マ診断薬
EP0145373B1 (en) * 1983-11-23 1992-03-25 The Ohio State University Research Foundation Purification of cancer-associated protein and preparation of antibody thereto
US4871661A (en) * 1983-11-23 1989-10-03 The Ohio State University Research Foundation Process for testing the carcinogenicity of a material or the presence of cancer-inducing factors in an environment
US4746539A (en) * 1983-11-23 1988-05-24 The Ohio State University Research Foundation Purification of cancer-associated protein and preparation of antibody thereto
US4607008A (en) * 1984-03-05 1986-08-19 American Hoechst Corporation Enzyme/immunofluorescent assay for anti-Epstein-Barr Virus antibodies
US4645737A (en) * 1984-03-05 1987-02-24 American Hoechst Corporation Enzyme/immunofluorescent assay for anti-treponemal antibodies
EP0162977B1 (en) * 1984-05-02 1992-05-20 University Research Corporation Enzyme immunoassay for cancer procoagulant
US4616658A (en) * 1985-02-27 1986-10-14 William Shell Non-radioactively labeled microspheres and use of same to measure blood flow
US4798719A (en) * 1986-09-11 1989-01-17 University Of Pittsburgh Method for selection of antigens suitable as in vivo targets for antibodies
US5019368A (en) * 1989-02-23 1991-05-28 Cancer Biologics, Inc. Detection of necrotic malignant tissue and associated therapy
US4861581A (en) * 1986-12-05 1989-08-29 Cancer Biologics, Inc. Detection of necrotic malignant tissue and associated therapy
CA2023030A1 (en) * 1990-07-13 1992-01-14 Robert R. Guerrero In vitro method and probe for detecting the presence of the ring shaped particle and malignancy in humans and animals

Also Published As

Publication number Publication date
CH659328A5 (de) 1987-01-15
ES498305A0 (es) 1982-08-01
AR232046A1 (es) 1985-04-30
FI810007A7 (fi) 1981-07-05
IL61641A0 (en) 1981-01-30
KR830003898A (ko) 1983-06-30
ES8307377A1 (es) 1983-06-16
SE450665B (sv) 1987-07-13
FI810007L (fi) 1981-07-05
AU535024B2 (en) 1984-03-01
PH18765A (en) 1985-09-20
KR850001770B1 (ko) 1985-12-18
ZA807754B (en) 1982-02-24
IE50760B1 (en) 1986-07-09
PT72301A (en) 1981-01-01
ES509239A0 (es) 1983-06-16
PT72301B (en) 1981-11-10
FR2484650B1 (fr) 1985-06-21
LU83015A1 (fr) 1981-06-04
PH18129A (en) 1985-03-22
PH18624A (en) 1985-08-21
DE3047654A1 (de) 1981-09-10
NZ195756A (en) 1983-11-18
PH18637A (en) 1985-08-23
FR2484650A1 (fr) 1981-12-18
DK554980A (da) 1981-07-05
ATA1081A (de) 1983-05-15
IT8167001A0 (it) 1981-01-05
IL61641A (en) 1984-03-30
NO850005L (no) 1981-07-06
AU6507080A (en) 1981-07-09
JPS56101553A (en) 1981-08-14
AT373397B (de) 1984-01-10
CA1157373A (en) 1983-11-22
GR72850B (oth) 1983-12-07
IE802533L (en) 1981-07-04
IT1172216B (it) 1987-06-18
GB2067286A (en) 1981-07-22
DE3047654C2 (oth) 1990-12-20
SE8100011L (sv) 1981-07-05
PH18636A (en) 1985-08-23
OA06713A (fr) 1982-06-30
GB2067286B (en) 1984-01-04
NL8007128A (nl) 1981-08-03
BE886935A (fr) 1981-04-16
ES8206855A1 (es) 1982-08-01

Similar Documents

Publication Publication Date Title
Gauthier et al. Distribution and properties of myosin isozymes in developing avian and mammalian skeletal muscle fibers
Coons et al. Localization of antigen in tissue cells: II. Improvements in a method for the detection of antigen by means of fluorescent antibody
NO803910L (no) Fremgangsmaate for immunologisk paavisning av kreft i vev hos mennesker.
KR100191118B1 (ko) 불임화 및 피임용 조나펠루시다항원과 항체의 제법과 용도
Bhattacharya et al. Immunologic studies of human serous cystadenocarcinoma of ovary. Demonstration of tumor‐associated antigens
Bell et al. Immunochemical and biochemical relationship between human pregnancy-associated secreted endometrial α1-and α2-globulins (α1-and α2-PEG) and the soluble placental proteins 12 and 14 (PP12 and PP14)
Colombatti et al. Glycoprotein 115, a glycoprotein isolated from chick blood vessels, is widely distributed in connective tissue.
Fargnoli et al. Identification of vitelline membrane proteins in Drosophila melanogaster
US4448890A (en) Detection of human cancer cells with antibodies to human cancer nucleolar antigens
US4196186A (en) Method for diagnosing malignant gliol brain tumors
JP2784200B2 (ja) 細胞組織標本の起源の同定方法
Bures et al. A comparative study of smooth muscle tumors utilizing light and electron microscopy, immunocytochemical staining and enzymatic assay
Björklund et al. Localization of synthesis of TPA in normal and malignant human tissues by immunohistological techniques
NO864091L (no) Antigener fra isolerte nukleoli og nukleaere ekstrakter samt diagnostisk utstyr for bruk ved immunologisk paavisning av kreft.
EP0689552B1 (en) A method of detecting rupture of the amniotic membranes in pregant mammals
EP0007214A1 (en) Product for detecting the presence of cancerous or malignant tumor cells
US4794077A (en) Detection of human cancer cells with anitbodies to human cancer nucleolar antigen p145
Charney et al. Demonstration, purification, and partial characterization of abnormal (HSL) antigens in stable human cell lines
Vanderbilt et al. Monoclonal antibodies to tissue-specific chromatin proteins.
NZ215887A (en) Tissue extracts with antitumor properties and compositions of them
US4840915A (en) Method for diagnosing malignant tumors
Misra Glomerular basement membrane antigens of Masugi nephritis
Sulitzeanu Antigenic components of rat connective tissue
CA1172165A (en) Detection of human cancer cells with antibodies to human cancer nucleolar antegen(s)
Busch et al. Antigenically active nonhistone chromatin proteins in cancer cells